Drug intelligence / Profile preview

Refresh Optive Fusion

Development stage
Unknown
Lead developer
AbbVie
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

Refresh Optive Fusion (also known as Optive Fusion) is an over-the-counter topical ophthalmic lubricant developed by Allergan (now a subsidiary of AbbVie) for the relief of moderate to severe dry eye syndrome. The formulation utilizes a dual-polymer technology that combines carboxymethylcellulose (CMC) and sodium hyaluronate. CMC acts as a mucoadhesive lubricant that provides sustained protection to the ocular surface, while sodium hyaluronate serves as a viscosity enhancer that improves water retention and hydration of the cornea. Additionally, the solution contains glycerin and erythritol, which function as osmoprotectants to stabilize the tear film and protect corneal epithelial cells from hyperosmotic stress. The product is typically preserved with Purite, which breaks down into natural tear components upon contact with the eye.

Brand names
Refresh Optive FusionOptive Fusion
Other names
carboxymethylcellulose sodium + glycerin + sodium hyaluronate + erythritolcarboxymethylcellulose 0.5% / glycerin 0.9% ophthalmic solution
02

Targets

GLUT1 (Glucose transporter 1)

Beyond the preview

Go deeper on Refresh Optive Fusion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Refresh Optive Fusion.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call